Stock Preacher and company are starting to pump. . . .
Cell Therapeutics, Inc. (CTIC) is in play this morning after a medical journal reported that a recent FDA trial of the company's cancer treatment worked on up to 80% of the test subjects. The news not only gave the stock a lift but pushed it up through the 10 Day Moving Average.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.